A case-control study of risk factors for hepatitis C infection in patients with unexplained routes of infection

KARMOCHKINE M. ; CARRAT F. ; O. DOS SANTOS ; P. CACOUB ; G. RAGUIN | 2006
Dans Journal of Viral Hepatitis (Vol.13, n°11, November 2006) Article : Périodique

Twenty to 40% of hepatitis C virus (HCV)-infected patients do not have a recognized parenteral risk factor, suggesting that still-unidentified modes of transmission exist. In order to investigate potential routes of HCV transmission for patients[...]

Plus d'info

Ajouter à la sélection

Management of chronic hepatitis C in French departments of internal medicine and infectious diseases

P. CACOUB ; GODEREL I. ; P. MORLAT ; SENE D. ; R. P. MYERS ; L. ALRIC ; LOUSTAUD-RATTI V. ; P. MÉLIN ; LIMAL N. ; D. OUZAN ; C. PERRONNE ; CARRAT F. ; THE GERMIVIC GROUP | 2005
Périodique

This prospective, multicentre study was conducted during 2-30 April 2001 in the internal medicine/infectious diseases services in France and included data from 1858 hepatitis C virus (HCV)-infected patients, half of whom were HIV co-infected. Th[...]

Plus d'info

Ajouter à la sélection

Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study)

E. ROSENTHAL ; M. POIREE ; C. PRADIER ; C. PERRONNE ; D. SALMON-CERON ; L. GEFFRAY ; R. P. MYERS ; P. MORLAT ; G. PIALOUX ; S. POL ; P. CACOUB | 2003
Périodique

Objective: To determine mortality due to end-stage liver disease (ESLD) in a nation- wide cohort of HIV-infected patients 5 years after the introduction of highly active antretroviral therapy (HAART) and to compare this with that observed before[...]

Plus d'info

Ajouter à la sélection